Abbott Laboratories
Abbott Laboratories (ABT) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ABT · as of Mar 31, 2025
Ownership Breakdown
3,250
Institutional Holders
▲ 100 vs Q4
$181.77B
Total Inst. Value
▲ $29.26B vs Q4
1.74B
Shares Outstanding
freeFloat 99.32%
1.37B
13F Shares Held
▲ 23.25M vs Q4
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ABT largest shareholders · institutional ownership
Q1 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
VANGUARD GROUP INC pharmaceutical preparations | 169.82M | 9.72% | 9.72% | $22.53T | May 9, 2025 | ▲ 1.18M |
BLACKROCK, INC. pharmaceutical preparations | 136.98M | 7.84% | 7.84% | $18.17T | May 2, 2025 | ▲ 442.6K |
STATE STREET CORP pharmaceutical preparations | 77.66M | 4.45% | 4.45% | $10.30T | May 15, 2025 | ▲ 497.1K |
CAPITAL INTERNATIONAL INVESTORS pharmaceutical preparations | 66.82M | 3.82% | 3.82% | $8.86T | May 12, 2025 | ▼ 1.15M |
CAPITAL RESEARCH GLOBAL INVESTORS pharmaceutical preparations | 50.73M | 2.90% | 2.90% | $6.73T | May 12, 2025 | ▼ 3.36M |
JPMORGAN CHASE & CO pharmaceutical preparations | 39.92M | 2.29% | 2.29% | $5.30T | May 12, 2025 | ▲ 4.74M |
GEODE CAPITAL MANAGEMENT, LLC pharmaceutical preparations | 36.90M | 2.11% | 2.11% | $4.88T | May 13, 2025 | ▲ 1.23M |
MORGAN STANLEY pharmaceutical preparations | 36.14M | 2.07% | 2.07% | $4.79T | May 15, 2025 | ▲ 20.0K |
WELLINGTON MANAGEMENT GROUP LLP pharmaceutical preparations | 29.76M | 1.70% | 1.70% | $3.95T | May 13, 2025 | ▲ 3.37M |
NORGES BANK pharmaceutical preparations | 21.76M | 1.25% | 1.25% | $2.89T | May 11, 2026 | ▲ 777.1K |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q1 2025 vs prior quarter
Q1 2025
25
Increased
+42.94M shares1
New Positions
first time holders23
Decreased
−16.41M shares0
Sold Out
fully exitedNet shares change (top 50)
+26.53M
+42.94M / −16.41M
Net new holders
+3
1 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ABT insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
19
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Moreland Mary K EXECUTIVE VICE PRESIDENT | Apr 28, 2026 | I-Discretionary | 5,314 | $94.41 | $501.7K | 17.2K | Form 4 ↗ |
Conroy Kevin T director | Apr 24, 2026 | Award | 2,286 | — | — | 133.7K | Form 4 ↗ |
Stratton John G director | Apr 24, 2026 | Award | 2,286 | — | — | 21.3K | Form 4 ↗ |
STARKS DANIEL J director | Apr 27, 2026 | Purchase | 10,000 | $92.65 | $926.5K | 6.75M | Form 4 ↗ |
STARKS DANIEL J director | Apr 24, 2026 | Award | 2,286 | — | — | 6.74M | Form 4 ↗ |
STARKS DANIEL J director | Apr 24, 2026 | Award | 7,105 | $91.86 | $652.7K | 7.1K | Form 4 ↗ |
Roman Michael F director | Apr 24, 2026 | Award | 2,286 | — | — | 10.8K | Form 4 ↗ |
O'Grady Michael director | Apr 24, 2026 | Award | 2,286 | — | — | 7.6K | Form 4 ↗ |
O'Grady Michael director | Apr 24, 2026 | Award | 5,929 | $91.86 | $544.6K | 5.9K | Form 4 ↗ |
McKinstry Nancy director | Apr 24, 2026 | Award | 2,286 | — | — | 41.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Abbott Laboratories (ABT) is primarily owned by institutional investors, who hold approximately 78.8% of total shares outstanding. Company insiders own approximately 0.68%, while retail and public investors account for the remaining 20.57%.
The largest institutional shareholder of Abbott Laboratories is VANGUARD GROUP INC, holding approximately 169.82 million shares — equal to 9.72% of outstanding shares — as of March 31, 2025.
A total of 3,250 institutional investors currently hold ABT stock, with a combined institutional value of approximately $181.77 billion as of the most recent 13F filing period.
Frequently asked questions
ABT ownershipAbbott Laboratories (ABT) is primarily owned by institutional investors, who hold approximately 78.8% of shares. The largest shareholder is VANGUARD GROUP INC with a 9.72% stake. Company insiders hold 0.68%. Data sourced from SEC Form 13F as of March 31, 2025.